Gilead Sciences, Inc. Profile Avatar - Palmy Investing

Gilead Sciences, Inc.

Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada,…
Drug Manufacturers - General
US, Foster City [HQ]
Lobbying · US Senate · Influence

Lobbying Analysis

FY Quarter Lobby Expense [in mil. $] Filing Report Time
2024 1 6 LDA-2 April 23, 2024, 12:07 a.m.
2024 1 6 LDA-2 April 22, 2024, 11:01 p.m.
2024 1 9 LDA-2 April 22, 2024, 9:11 p.m.
2024 1 6 LDA-2 April 22, 2024, 7:25 p.m.
2024 1 5 LDA-2 April 22, 2024, 4:17 p.m.
2024 1 8 LDA-2 April 22, 2024, 2:57 p.m.
2024 1 8 LDA-2 April 19, 2024, 7:12 p.m.
2024 1 7 LDA-2 April 17, 2024, 2:34 p.m.
2024 1 8 LDA-2 April 13, 2024, 2:10 p.m.
2024 1 5 LDA-2 April 12, 2024, 8 p.m.
2022 4 8 LDA-2 Feb. 7, 2024, 4:12 p.m.
2023 4 5 LDA-2 Jan. 23, 2024, 4:28 a.m.
2023 4 9 LDA-2 Jan. 22, 2024, 11:30 p.m.
2023 4 8 LDA-2 Jan. 22, 2024, 9:32 p.m.
2023 4 6 LDA-2 Jan. 21, 2024, 4:42 a.m.
2023 4 5 LDA-2 Jan. 19, 2024, 9:21 p.m.
2023 4 6 LDA-2 Jan. 19, 2024, 7:53 p.m.
2023 4 5 LDA-2 Jan. 19, 2024, 2:35 p.m.
2023 4 6 LDA-2 Jan. 19, 2024, 3:14 a.m.
2023 4 7 LDA-2 Jan. 18, 2024, 6:22 p.m.
2023 4 8 LDA-2 Jan. 18, 2024, 3:43 p.m.
2023 4 8 LDA-2 Jan. 17, 2024, 3:01 a.m.
2023 4 5 LDA-2 Jan. 13, 2024, 10:14 p.m.
End of GILD's Analysis
CIK: 882095 CUSIP: 375558103 ISIN: US3755581036 LEI: - UEI: -
Secondary Listings
XETRA:GIS.DE